Type 2 diabetes target the cardiorenal system
This CPD-accredited report highlights all the new evidence and the best therapies available while also addressing the primary concern of HbA1c
You will learn:
• The risk factors that lead to cardiac and renal dysfunction
• The usefulness of bio-profiling and precision medicine in the management of the individual with diabetes
• The evidence for SGLT-2 inhibitors in the treatment of cardiorenal syndrome.
To access this module, please register or login: